1. A pharmaceutical composition in tablet form containing as active ingredient 6-methyl-2-ethylpyridine-3-ol, salt of (2S) -2-atsetaminopentandiovoy acid in a pharmacologically effective dose, as well as auxiliary veschestva.2. A pharmaceutical composition according to Claim. 1 comprising 6-methyl-2-ethylpyridine-3-ol, salt of (2S) -2-atsetaminopentandiovoy acid at a dose of 50-200 mg.3. A pharmaceutical composition according to claim. 2 comprising 6-methyl-2-ethylpyridine-3-ol, salt of (2S) -2-atsetaminopentandiovoy acid at a dose of 50 mg or 75 mg or 100 MG4. Pharmaceutical composition according to paragraphs. 1-3, made in the form of tablets, enteric-coated obolochkoy.5. Pharmaceutical composition in the form of tablets, enteric-coated, containing 6-methyl-2-ethylpyridine-3-ol, salt of (2S) -2-atsetaminopentandiovoy acid as active ingredient and excipients include microcrystalline cellulose, lactose monohydrate, crospovidone, . magnesium stearate, colloidal silicon dioxide, in the following ratio, wt%: Excipients: 6. A pharmaceutical composition according to claim 5, characterized in that the enteric coating comprises film coating "Acrylic - from white" film coating "Opadry II White" and macrogol, with the following ratio of components, wt% for the tablet: 7.. .. A pharmaceutical composition according to claim 5, characterized in the following ratio, wt%: Excipients: 8. A pharmaceutical composition according to any one of claims. 5-7, wherein the following component ratio, wt.%: 6-methyl-2-ethylpyridine-3-ol solVspomogatelnye substances: enteric coating 9. A method of preparing a pharmaceutical component1. Фармацевтическая композиция в форме таблеток, содержащая в качестве активного компонента 6-метил-2-этилпиридин-3-ол соль (2S)-2-ацетаминопентандиовой кислоты в фармакологически эффективной дозе, а также вспомогательные вещества.2. Фармацевтическая композиция по п. 1, содержащая 6-метил-2-этилпиридин-3-ол соль (2S)-2-ацетаминопентандиовой кислоты в дозе 50-200 м
